Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...
The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...
Key non-cystic fibrosis bronchiectasis companies such as Zambon SpA, Insmed, Armata Pharmaceuticals, Verona Pharma, Haisco Pharmaceutical Group, Infex therapeutics, Boehringer Ingelheim, Regeneron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback